** Shares of biotech firm Evaxion Biotech EVAX.O fall 28.6% to $2.42
** EVAX says it is raising $10.8 mln through public offering
** EVAX is selling ~4 mln of its American Depositary Shares at $2.71/shr, along with warrants to buy additional shares
** Offering priced at 20% discount to stock's last close
** Funds will be used to advance EVAX's vaccine development pipeline and cover operating expenses, co says
** EVAX has ~1.2 mln outstanding shares, with market cap of ~4 mln - LSEG data
** Lake Street Capital Markets and Jones are acting as exclusive placement agents for offering
** EVAX fell ~91% in 2024
(Reporting by Kamal Choudhury in Bengaluru)
((Kamal.Choudhury@thomsonreuters.com;))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。